Sectors

BLCO
Bausch + Lomb Corporation
15.93
2 x 15.92
3 x 15.95
bid
ask
-
0.06
0.38%
01:29 PM
timesize
Ytd-6.73%
1y11.40%
15.90
day range
16.14
13.09
52 week range
18.91
Open16.01Prev Close15.99Low15.90High16.14Mkt Cap5.70B
Vol82.47KAvg Vol456.96KEPS0.65P/E24.60Forward P/E14.37
Beta0.56Short Ratio8.80Inst. Own11.02%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-2950-d Avg15.89200-d Avg16.271yr Est18.14

BLCO News

Bausch + Lomb Launches EyeGility Inserter for enVista IOLs in the U.S.
zacks.com
Bausch + Lomb Launches EyeGility Inserter for enVista IOLs in the U.S.

BLCO launches EyeGility in the United States, pairing preloaded enVista Aspire lenses with smoother

benzinga.com
Bausch + Lomb Announces U.S. Launch Of EyeGility Inserter Preloaded IOL Delivery System

EyeGility is designed for the enVista® family of IOLsOffers balanced push force for smooth delivery,

Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States
businesswire.com
Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

Bausch + Lomb Ends Glaucoma Drug Development, Shifts Focus
benzinga.com
Bausch + Lomb Ends Glaucoma Drug Development, Shifts Focus

Bausch + Lomb ended BL1107 glaucoma eye drop development after a Phase 2 miss and will focus on a su

benzinga.com
Bausch + Lomb Announces Phase 2 Topline Results For BL1107 In Glaucoma; Study Did Not Meet Primary E

Phase 2 study did not meet its primary endpoint.Company will discontinue development of eye drops fo

Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
businesswire.com
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

benzinga.com
Bausch + Lomb Creates Orphia, New AI-Powered Digital Health Platform

Designed to reduce the operational burden that stands between physicians and their patients.Initial

Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
businesswire.com
Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians t

VAUGHAN, Ontario, & MENLO PARK, Calif.--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO),

benzinga.com
Evercore ISI Group Maintains In-Line on Bausch & Lomb, Raises Price Target to $17

Evercore ISI Group analyst Vijay Kumar maintains Bausch & Lomb (NYSE:BLCO) with a In-Line and

Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
businesswire.com
Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lower Anxiety and Increased Self-Confidence
businesswire.com
New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

Bausch + Lomb Corporation (BLCO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
seekingalpha.com
Bausch + Lomb Corporation (BLCO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference

Bausch + Lomb Corporation (BLCO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference

Bausch + Lomb Corporation (BLCO) Discusses Project Halo and Myopia Control Developments in Vision Care Transcript
seekingalpha.com
Bausch + Lomb Corporation (BLCO) Discusses Project Halo and Myopia Control Developments in Vision Ca

Bausch + Lomb Corporation (BLCO) Discusses Project Halo and Myopia Control Developments in Vision Ca

Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
businesswire.com
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
businesswire.com
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results
businesswire.com
Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win
247wallst.com
Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under

With consumer sentiment sitting at 53.3 in March 2026, deep in pessimistic territory, retail investo

Bausch + Lomb Announces Second R&D “Teach-in” Webinar
businesswire.com
Bausch + Lomb Announces Second R&D “Teach-in” Webinar

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting
businesswire.com
Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vis

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

Bausch + Lomb Corporation (BLCO) Q1 2026 Earnings Call Transcript
seekingalpha.com
Bausch + Lomb Corporation (BLCO) Q1 2026 Earnings Call Transcript

Bausch + Lomb Corporation (BLCO) Q1 2026 Earnings Call Transcript

Bausch + Lomb (BLCO) Surpasses Q1 Earnings and Revenue Estimates
zacks.com
Bausch + Lomb (BLCO) Surpasses Q1 Earnings and Revenue Estimates

Bausch + Lomb (BLCO) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensu

Earnings Scheduled For April 29, 2026
benzinga.com
Earnings Scheduled For April 29, 2026

Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook
businesswire.com
Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

Bausch + Lomb Releases 2025 Sustainability Impact Report
businesswire.com
Bausch + Lomb Releases 2025 Sustainability Impact Report

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program
businesswire.com
Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collec

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

Comparing Biodesix (NASDAQ:BDSX) & Bausch + Lomb (NYSE:BLCO)
defenseworld.net
Comparing Biodesix (NASDAQ:BDSX) & Bausch + Lomb (NYSE:BLCO)

Biodesix (NASDAQ: BDSX - Get Free Report) and Bausch + Lomb (NYSE: BLCO - Get Free Report) are both

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Earnings Scheduled For February 18, 2026
benzinga.com
Earnings Scheduled For February 18, 2026

Earnings Scheduled For October 29, 2025
benzinga.com
Earnings Scheduled For October 29, 2025

benzinga.com
Earnings Scheduled For July 30, 2025

benzinga.com
Earnings Scheduled For April 30, 2025

benzinga.com
Earnings Scheduled For February 19, 2025

benzinga.com
Earnings Scheduled For February 21, 2024

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly ear

benzinga.com
Earnings Scheduled For February 22, 2023

Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its

benzinga.com
Earnings Scheduled For November 2, 2022

Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for i